Urokinase-Deficient Mice Fail to Generate a Type 2 Immune Response following Schistosomal Antigen Challenge

Infection and Immunity

Volumn 72, Issue 1, 2004, Pages 461-467

  Gyetko, Margaret R ^a,c   Sud, Sudha ^a   Chensue, Stephen W ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; PARASITE ANTIGEN; SCHISTOSOMAL EGG ANTIGEN; UNCLASSIFIED DRUG; UROKINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL POLARITY; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; EOSINOPHIL; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; KNOCKOUT MOUSE; LUNG GRANULOMA; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SCHISTOSOMA; T LYMPHOCYTE; TH2 CELL;

ANIMALS; ANTIGENS, HELMINTH; CYTOKINES; GRANULOMA, RESPIRATORY TRACT; HYPERSENSITIVITY, DELAYED; IMMUNOGLOBULIN E; LYMPHOCYTE ACTIVATION; MICE; SCHISTOSOMA; SCHISTOSOMIASIS; T-LYMPHOCYTES; TH2 CELLS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0346251025     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.1.461-467.2004     Document Type: Article

References (41)

1. Abbas, A. K., J. S. Pober, and A. H. Lichtman (ed.). 1994. Cellular and molecular immunology. W. B. Saunders Company, Philadelphia, Pa.
2. Angelici, E., C. Contini, R. Romani, O. Epifano, P. Serra, and R. Canipari. 1996. Production of plasminogen activator and plasminogen activator inhibitors by alveolar macrophages in control subjects and AIDS patients. AIDS 10:283-290.
3. Beck, J., A. Preston, and M. Gyetko. 1999. Urokinase-type plasminogen activator in inflammatory cell recruitment and host defense against Pneumocystis carinii in mice. Infect. Immun. 67:879-884.
4. Bianchi, E., E. Ferrero, F. Fazioli, F. Mangeili, J. Wang, J. Bender, F. Blasi, and R. Pardi. 1996. Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes. J. Clin. Investig. 98:1133-1141.
5. Busso, N., M. Collart, J. D. Vassalli, and D. Belin. 1987. Antogonist effect of RU 486 on transcription of glucocorticoid-regulated genes. Exp. Cell Res. 173:425-430.
6. Carmeliet, P., L. Schoonjans, L. Kieckens, B. Ream, J. Degen, R. Bronson, R. De Vos, J. J. van den Oord, D. Collen, and R. C. Mulligan. 1994. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368:419-424.
7. Chapman, H. A., J. J. Reilly, and L. Kobzik. 1988. Role of plasminogen activator in degradation of extracellular matrix proteins by live human alveolar macrophages. Am. Rev. Respir. Dis. 137:412-419.
8. Chensue, S. W., N. W. Lukacs, T. Y. Yang, X. Shang, K. A. Frait, S. L. Kunkel, T. Kung, M. T. Wiekowski, J. A. Hedrick, D. N. Cook, A. Zingoni, S. K. Narula, A. Zlotnik, F. J. Barrat, A. O'Garra, M. Napolitano, and S. A. Lira. 2001. Aberrant in vivo T helper type 2 cell response and impaired eosinophil recruitment in CC chemokine receptor 8 knockout mice. J. Exp. Med. 193:573-584.
9. Chensue, S. W., K. S. Warmington, J. H. Ruth, P. Lincoln, and S. L. Kunkel. 1995. Cytokine function during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation. J. Immunol. 154:5969-5976.
10. Cohn, L., C. Herrick, N. Niu, R. Homer, and K. Bottomly. 2001. IL-4 promotes airway eosinophilia by suppressing IFN-gamma production: defining a novel role for IFN-gamma in the regulation of allergic airway inflammation. J. Immunol. 166:2760-2767.
11. Couissinier-Paris, P., and A. J. Dessein. 1995. Schistosoma-specific helper T cell clones from subjects resistant to infection by Schistosoma mansoni are Th0/2. Eur. J. Immunol. 25:2295-2302.
12. Danø, K., P. Andreasen, J. Grondahl-Hansen, P. Kristensen, L. Nielsen, and L. Skriver. 1985. Plaminogen activators, tissue degradation, and cancer. Adv. Cancer Res. 44:139-265.
13. Estreicher, A., J. Mühlhause, J. Carpentier, L. Orci, and J. Vassalli. 1990. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J. Cell Biol. 111:783-792.
14. Gunderson, D., C. Tran-Thang, B. Sordat, F. Mourali, and C. Ruegg. 1997. Plasmin-induced proteolysis of Tenascin-C. Modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering. J. Immunol. 158:1051-1060.
15. Gyetko, M. R., G.-H. Chen, R. A. McDonald, R. Goodman, G. B. Huffnagle, C. C. Wilkinson, J. A. Fuller, and G. B. Toews. 1996. Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans: a murine transgenic model. J. Clin. Investig. 97:1818-1826.
16. Gyetko, M. R., E. A. Libre, J. A. Fuller, G.-H. Chen, and G. B. Toews. 1999. Urokinase is required for T lymphocyte proliferation in vitro. J. Lab. Clin. Med. 133:274-288.
17. Gyetko, M. R., S. Sud, G.-H. Chen, J. A. Fuller, S. W. Chensue, and G. B. Toews. 2002. Urokinase-type plasminogen activator is required for the generation of a type 1 immune response to pulmonary Cryptococcus neoformans infection. J. Immunol. 168:801-809.
18. Gyetko, M. R., S. Sud, T. Kendall, J. A. Fuller, M. W. Newstead, and T. Standiford. 2000. Urokinase receptor-deficient transgenic mice have impaired neutrophil recruitment in response to pulmonary pseudomonas infection. J. Immunol. 165:1513-1519.
19. Gyetko, M. R., S. Sud, J. Sonstein, T. Polak, A. Sud, and J. L. Curtis. 2001. Cutting edge: Antigen-driven lymphocyte recruitment to the lung is diminished in the absence of urokinase-type plasminogen activator (uPA) receptor, but is independent of uPA. J. Immunol. 167:5539-5542.
20. Hamilton, J. A., G. A. Whitty, J. Wojta, M. Gallichio, K. McGrath, and G. Ianches. 1993. Regulation of plasminogen activator inhibitor-1 levels in human monocytes. Cell Immunol. 152:7-17.
21. Hoag, K. A., M. F. Lipscomb, A. A. Izzo, and N. E. Street. 1997. IL-12 and IFN-γ are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice. Am. J. Respir. Cell Mol. Biol. 17:733-739.
22. Joseph, M., C. Auriault, A. Capron, H. Vorng, and P. Viens. 1983. A new function for platelets: IgE-dependent killing of schistosomes. Nature 303:810-812.
23. Kirchheimer, J. C., and H. G. Remold. 1989. Endogenous receptor-bound urokinase mediates tissue invasion of human monocytes. J. Immunol. 143:2634-2639.
24. MacKenzie, J. R., J. Mattes, and L. A. Dent. 2001. Eosinophils promote allergic disease of the lung by regulating CD4(+) Th2 lymphocyte function. J. Immunol. 167:3146-3155.
25. Mawhorter, S. D., J. W. Kazura, and W. H. Boom. 1994. Human eosinophils as antigen-presenting cells: relative efficiency for superantigen- and antigen-induced CD4+ T-cell proliferation. J. Immunol. 81:584.
26. Metwali, A., A. Blum, D. E. Elliot, and J. V. Weinstock. 2002. Interleukin-2 receptor alpha chain and STAT 6 signaling inhibit gamma interferon but not Th2 cytokine expression within schistosome granulomas. Infect. Immun. 70:5651-5658.
27. Metwali, A., D. Elliott, A. M. Blum, and J. V. Weinstock. 1993. Granuloma eosinophils enhance IL-5 production by lymphocytes from mice infected with Schistosoma mansoni. J. Immunol. 151:7048.
28. Miles, L. A., and E. F. Plow. 1987. Receptor mediated binding of the fibrinolytic components, plasmonogen and urokinase to peripheral blood cells. Thromb. Haemostas. 58:936.
29. Nykjaer, A., B. Møller, R. F. Todd III, T. Christensen, P. A. Andreasen, J. Gliemann, and C. M. Petersen. 1994. Urokinase receptor: an activation antigen in human T Lymphocytes. J. Immunol. 152:505-516.
30. Okano, M., A. R. Satoskar, K. Nishizaki, M. Abe, and D. A. J. Harn. 1999. Induction of Th2 responses and IgE is largely due to carbohydrates functioning as adjuvants on Schistosoma mansoni egg antigens. J. Immunol. 163:6712-6717.
31. Pearce, E. J., A. La Flamme, E. Sabin, and L. Rosa Brunet. 1998. The initiation and function of Th2 responses during infection with Schistosoma mansoni. Adv. Exp. Med. Biol. 452:67-73.
32. Pedras-Vasconcelos, J. A., L. R. Brunet, and E. J. Pearce. 2001. Profound effect of the absence of IL-4 on T cell responses during infection with Schistosoma mansoni. J. Leukoc. Bio. 70:737-744.
33. Rosa Brunet, L. R., F. D. Firkelman, A. W. Cheever, M. A. Kopf, and E. J. Pearce. 1997. IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis. J. Immunol. 159:777-785.
34. Sabin, E. A., M. A. Kopf, and E. J. Pearce. 1996. Schistosoma mansoni egg-induced early IL-4 production is dependent upon IL-5 and eosinophils. J. Exp. Med. 184:1871.
35. Sabin, E. A., and E. J. Pearce. 1995. Early IL-4 production by non-CD4+ cells at the site of antigen deposition predicts the development of a T helper 2 cell response to Schistosoma mansoni eggs. J. Immunol. 155:4844-4853.
36. Saksela, O., and D. B. Rifkin. 1988. Cell-associated plasminogen activation: regulation and physiological functions. Annu. Rev. Cell Biol. 4:93-126.
37. Shang, X. Z., B. C. Chiu, V. Stolberg, N. W. Lukacs, S. L. Kunkel, H. S. Murphy, and S. W. Chensue. 2002. Eosinophil recruitment in type-2 hypersensitivity pulmonary granulomas: source and contribution of monocyte chemotactic protein-3 (CCL7). Am. J. Pathol. 161:257-266.
38. Smith, S., D. W. Dunne, and P. G. Fallon. 2001. Defective in vivo induction of functional type 2 cytokine responses in aged mice. Eur. J. Immunol. 31:1495-1502.
39. Traynor, T. R., W. A. Kuziel, G. B. Toews, and G. B. Huffnagle. 2000. CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection. J. Immunol. 164:2021-2027.
40. Vassalli, J., A. Sappino, and D. Belin. 1991. The plasminogen activator/plasmin system. J. Clin. Investig. 88:1067-1072.
41. Wynn, T. A., D. Jankovic, S. Hieny, A. W. Cheever, and A. Sher. 1995. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. J. Immunol. 154:4701-4709.